IL33 and dysplasia: We found that patients with dysplasia had lower levels of IL‐33, BCA‐1, GRO, CCL19 (MIP‐3B), sTNFRII, CXCL6 (GCP2), CRP and MIP‐1B compared to gallstones patients without dysplasia.